#52026M12363Prior Notification of GBL and CVC Joint Acquisition of Rayner
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
The law involves a proposed joint acquisition where Groupe Bruxelles Lambert and CVC Capital Partners will gain control of UK-based Rayner Surgical Group. This change primarily impacts stakeholders in the ophthalmic surgical products market as Rayner is a key player in this sector. The European Commission invites third parties to submit observations on this acquisition, which could be treated under a simplified procedure due to its scope.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- GBL and CVC's joint control acquisition of Rayner Surgical Group
- Potential treatment under EU's simplified merger procedure
- Opportunity for third parties to submit observations
Obligations
What this law requires
Interested third parties must submit their observations on the proposed concentration to the Commission.
Interested third parties must submit observations on the proposed concentration to the Commission.
Observations must reference 'M. 12363 – GBL / CVC / RAYNER' when submitted.
Observations must specify the reference: M. 12363 – GBL / CVC / RAYNER.
Observations can be submitted via email or post to the specified contact details.